key: cord-0948792-vmcr4s6s authors: Chandra, Somesh; Rawal, Rakesh title: The Surge in Covid related Mucormycosis date: 2021-06-12 journal: J Infect DOI: 10.1016/j.jinf.2021.06.008 sha: df9310e1593dc751ebd748373f5b94ed069d4889 doc_id: 948792 cord_uid: vmcr4s6s nan . The point to ponder therefore is, whether SARSCoV2 is the major culprit which compromises the immune system of the host and thereby make the host more vulnerable to this secondary opportunistic infection, thus accounting for higher incidence of MM during second wave in India? Earlier published literature including several retrospective case series analyses have reported vulnerability of immune-compromised patients with pre-existing comorbidities e.g. diabetic ketoacidosis(DKA) treated with systemic glucocorticoids, Zn supplement, and longer ICU stay with O2 support towards mucormycosis(3-7). However, These observations are not backed by sufficient scientific evidence to account for the proportionately higher Covid-associated MM in the second wave. There are several clinical forms of MM infection reported till date including pulmonary, gastrointestinal, cutaneous, and rhinocerebral (8) . MM has a typical clinical presentation characterized by rapid progression of tissue necrosis due to sequential invasion and thrombosis of blood vessels. Rhinocerebro-orbital mucormycosis, the major form in this pandemic is diagnosed through CT paranasal sinus and MRI brain (9, 10) . It is now known that the surge in second wave is related, at least in part, to the new variants of concern in the SARSCOV-2 virus making it more transmissible and difficult to treat (11, 12) . It was well established that the virus gains entry into cells using the ACE-2 receptors (13) . A greater rate of endocytosis will be facilitated if the virus has additional "routes" of entry. Ibrahim et al and others have reported that the GRP 78 could act as an alternative and additional route for the virus to gain entry into the host cell (14, 15) . The genome of the prevalent SARSCoV2 variant (B.1.1.7 & B.6.117) in India is believed to be the cause of the increased infection (16, 17) . In-silico studies have shown stable interaction between RBD domain of spike protein (C480-488,) with that of GRP 78 predicting its role in endocytosis (18, 19) . It is to be noted that MM also have the same port of entry i.e GRP78 into the nasal and paranasal sinus mucosa through its coat protein CotH3 (20) . Two hypotheses can be formulated for over expression of GRP78 one due to High glucose and iron content found during DKA and second dexamethasone induced GRP78 expression and thus may facilitate the invasion of MM into target cells for further proliferation (21) (22) (23) . There is still a less explored reason for GRP78 over expression namely endoplasmic reticulum(ER) stress. In perfectly healthy condition, the protein folding ability of endoplasmic reticulum matches with the body's protein synthesis ability. However, in stress condition e.g. virus infection cells accumulates excessively high number of unfolded viral structural proteins in ER leading to over expression of GRP78 at cell surface making the cells vulnerable to fungal pathogens e.g. MM (24) . The GRP 78 binding being common to both the new variants as well as MM, could explain both the higher transmissibility of SARSCoV2 and surge in COVID-19 associated MM in the second wave. We propose, therefore, that this is the right time to conduct a stringent medical audit of MM cases with a detailed questionnaire and medical records to identify risk predictors for future plans of action. Assessment of GRP78 expression in target cells or in circulation during hospital discharge, If not in all cases, at least in high-risk individuals like diabetics supplemented with steroid and had a history of long Mucormycosis in immunochallenged patients Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature Rise of the phoenix: Mucormycosis in COVID-19 times COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world? COVID-19 and orbital mucormycosis Mucor in a Viral Land: A Tale of Two Pathogens Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU Rhino-Orbital Mucormycosis Associated With COVID-19 Mucormycosis with orbital compartment syndrome in a patient with COVID-19 Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospitalbased cohort study Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 COVID-19 spike-host cell receptor GRP78 binding site prediction Host-Pathogen Molecular Factors Contribute to the Pathogenesis of Rhizopus spp. in Diabetes Mellitus Coronavirus variants are spreading in india -what scientists know so far (News in Focus) Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study Host-cell recognition through GRP78 is enhanced in the new variants of SARS-CoV-2; in silico perspective Letter to the Editor Overexpression of GRP78 receptor and its Chemical Biology in Cancer and Autoimmune Diseases: High risk for COVID 19? OSF Preprints High GRP78 levels in Covid-19 infection: A case-control study GRP78 targeting: Hitting two birds with a stone Targeting the GRP78-Dependant SARS-CoV-2 Cell Entry by Peptides and Small Molecules GRP78: A cell's response to stress